简要报告:马拉维艾滋病毒感染者移动男性中长效注射性ART的声明偏好:一种定性研究
Marguerite Thorp1, Sam Phiri2, Khumbo Phiri2
1Division of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA; and.
Journal of acquired immune deficiency syndromes (1999)
|January 10, 2025
概括
在马拉维,携带艾滋病毒的移动男性更喜欢长效注射药 (LAI) 而不是每日口服抗逆转录病毒疗法 (ART). 在这个人群中,LAI提供了谨慎的剂量,并降低了与每日服用药物的风险.
科学领域:
- 艾滋病毒/艾滋病 治疗
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 长效注射性抗逆转录病毒药物 (LAI) 与每日口服ART相比,提供有效,谨慎和较少的剂量.
- 其他治疗剂可能会改善每日口服方案面临挑战的个体的治疗坚持,例如携带艾滋病毒的移动男性 (MLHIV).
研究的目的:
- 探索马拉维艾滋病毒感染者 (MLHIV) 移动男性在长期注射抗逆转录病毒疗法 (LAI) 和每日口服ART方面的偏好.
- 了解这些偏好背后的推理,特别是关于遵守和披露的理由.
主要方法:
- 在马拉维的两个家长试验中进行了一项定性副研究.
- 对29名移动MLHIV患者进行了深入采访,他们之前曾服用过口服ART.
- 框架分析用于分析采访数据,以分析LAI与口服ART的偏好.
主要成果:
- 大多数移动MLHIV患者 (26/29) 表示他们更喜欢LAI而不是每日口服ART.
- 偏好LAI的主要原因包括降低忘记药丸的风险,避免不必要的披露.
- 一些参与者也注意到对可能影响工作的注射部位反应的担忧.
结论:
- 马拉维的移动MLHIV具有坚持挑战,显示出对LAI的强烈偏好,而不是每日口服ART.
- 进一步的研究对于解决实施挑战和评估LAI在难以接触的人群中的有效性至关重要.
相关概念视频
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
01:30Modified-Release Drug Delivery Systems: Bioavailability
170
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
170
01:27Insulin Formulations: Types and Delivery
1.2K
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
1.2K